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Background: Cervical nodal status is one of prognostic factors in head and neck squamous cell carcinoma (HNSCC).
The objective of this study was to identify prognostic factors of cervical node status including site and size of primary
tumors, presence of lymphovascular invasion, and size of cervical node for appropriate further treatment in HNSCC.
Methods: A 5-year retrospective review of patients with HNSCC in Phramongkutklao Hospital from 2009 to 2013 was
conducted. Histopathologic data on primary tumors and cervical nodes were reviewed. Cervical nodes were divided
into five groups: 1–3, 4–6, 7–9, 10–30, and >30 mm. Numbers of positive and negative nodes were compared in
different sizes and sites and the presence of extracapsular extension.
Results: In all, 165 patients and 1,472 nodes were reviewed. The mean age was 52.6 years and 77.58% were male.
The most frequent primary site was oral tongue (50.91%). In sum, 52.72% showed lymphovascular invasion.
Thirty-five patients (81.40%) in therapeutic neck dissections and 18 patients (69.23%) in prophylactic neck dissections
showed nodal metastasis. The mean size of metastatic nodes was 3.89 mm (range, 2–45 mm) and 3.53 mm (range,
2–23 mm), respectively. Significant associations were found between the size of cervical nodes and the site of primary
tumor of the oral tongue, lip, base of the tongue, and floor of the mouth (p < 0.05). Metastatic lymph nodes showed
extracapsular extension 69.55%. No significance was found between extracapsular extension and clinical staging, size
of primary tumor, pathologic differentiation, and size of cervical nodes. Sizes of cervical lymph node of squamous cell
carcinoma (SCC) of the oral tongue and lip were statistically significant with the size of tumor and tumor grading
(p < 0.05).
Conclusions: A statistical significance was found between the size of cervical nodes and the site of primary tumor of
the oral tongue and lip. Herein, we recommended performing neck dissection in all cases of SCC of the base of the
tongue, floor of the mouth, buccal mucosa, and retromolar trigone.
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Head and neck squamous cell carcinoma (HNSCC) is
one of the most common malignant tumors of the skin
and oral cavity. Early diagnosis and treatment have a
favorable prognosis. Regional metastasis of HNSCC is
most likely to involve the cervical lymph node. Nodal
status is one of prognostic factor and affects the survival
rate of patients. Then, accurate staging of cervical lymph
node is necessary. Histopathologic confirmation of meta-
static node is the method to provide the final staging.* Correspondence: pataranat@hotmail.com
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unless otherwise stated.The investigations including computed tomography
(CT) [1,2], magnetic resonance imaging (MRI) [3-5],
positron emission tomography (PET) [6,7], and Doppler
ultrasound [8] give more information to identify lymph
nodes. Moreover, the biomarker study for prognostic
factors such as matrix metalloproteinase-13 (MMP-13)
[9], cyclooxygenase-2 (COX-2) expression [10], and gene
expression (molecular analysis) marker [11] can predict
occult metastasis but the accuracy is inconclusive.
The size of cervical lymph node is the guideline for
operative procedures. Usually, cervical nodes larger than
10 mm are significant for nodal metastasis and the oper-
ation is a radical neck dissection. However, pathologically
identified neck node metastasis occurs in 34%–51% ofral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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neck dissections [12,13].
At present, size criterion to diagnose occult malignant
nodes is not reliable and presents a challenge for the
surgeon to determine the extension of neck dissection.
The association between nodal metastasis and size of
cervical node is inconclusive and controversial.
The objective of this study was to identify prognostic
factors of cervical node status including the site and size
of primary tumors, presence of lymphovascular invasion,
and size of cervical node for appropriate further treat-
ment in HNSCC.
Methods
Approval of this study was obtained from the ethics
committee of Phramongkutklao Hospital and College of
Medicine. A 5-year retrospective review of patients with
HNSCC in Phramongkutklao Hospital from 2009 to
2013 was conducted.
Inclusion criteria were patients with squamous cell
carcinoma (SCC) of the lips, oral tongue, base of the
tongue, floor of the mouth, buccal mucosa, alveolar, and
retromolar trigone. The patients with non-SCC and can-
cer of the thyroid, pharynx, larynx, tonsils, and salivary
glands were excluded.
The database included age, sex, tumor site, tumor size,
tumor staging, histopathologic data of primary tumors
and cervical nodes, presence of cervical lymph node
metastasis, and treatment modality. Histopathologic data
of primary tumors included differentiation of tumor,
presence of lymphovascular invasion, and perineural
invasion. The differentiation of tumor was dependent on
features such as nuclear and cytoplasmic differentiation
and degree of keratinization and was divided in a four-
grade system. Tumor differentiations were described as
well differentiated, moderately differentiated, poorly dif-
ferentiated, and undifferentiated.
The surgery of cervical neck nodes was divided into
therapeutic neck dissection and prophylactic neck dis-
section. The therapeutic dissection was defined as neck
dissection in patients with palpable cervical lymph
nodes, or if the investigation showed cervical nodes larger
than 8 mm, it was defined as radical neck dissection or
modified neck dissection. Prophylactic neck dissection
was performed in patients with tumor size more than 2
cm and all cases of the base of the tongue. Prophylactic
neck dissection was defined as modified neck dissection
or supraomohyoid neck dissection.
All cervical nodes were reviewed including the size
of the node, presence of metastasis, and extracapsular
extension under a microscope by an experienced path-
ologist. Cervical nodes were divided into five groups:
1–3, 4–6, 7–9, 10–30, and >30 mm. Cervical nodes
were compared in different sizes, extracapsular extension,and number of positive and negative nodes at each site of
HNSCC.
Statistic analysis
Correlation between cervical nodes and tumors was
analyzed. The univariate analysis of the independent
variables was accomplished using Fisher’s exact test or
chi-square test. A p value <0.05 was considered statisti-
cally significant.
Results
A total of 204 patients with HNSCC were recorded.
Thirty-nine patients were excluded because of refused
treatment, comorbidity, distant metastasis, and unavail-
ability of medical records. The remaining 165 patients
with HNSCC were reviewed. Overall, the mean age of
the patients was 52.6 years (range, 23 to 89 years)
(Table 1). Of these patients, 50.3% ranged in age from 45
to 60 years. There were 128 (77.58%) male and 37
(22.42%) female. Oral tongue was the most frequent pri-
mary site (50.91%) and retromolar trigone was the least
(3.03%). Clinical stage I, stage II, stage III, and stage IV
were diagnosed in 60.00%, 13.94%, 13.94%, and 12.12%,
respectively. Tumor sizes were classified in five categor-
ies, 22.42% were smaller than 1 cm and 39.39% ranged
in sizes between 1.1 and 2.0 cm. Eighty-six patients
(52.12%) were categorized as having well differentiated,
49 (29.70%) as moderately differentiated, 25 (15.15%) as
poorly differentiated, and 5 (3.03%) as undifferentiated
lesions.
Sixty-nine patients (41.82%) underwent neck dissec-
tion and 1,472 nodes were found and reviewed (Table 2).
The mean number of nodes was 21.33 nodes per patient.
According to the histopathology reviewed, 87 patients
(52.72%) showed lymphovascular invasion (Table 3).
Lymphovascular invasion of SCC of the oral tongue,
base of the tongue, lip, floor of the mouth, buccal mucosa,
and retromolar trigone were 42.85%, 66.67%, 58.06%,
57.89%, 72.72%, and 80.00%, respectively. No statistical
significance was found among lymphovascular invasion
of primary tumor, clinical staging, and pathologic dif-
ferentiation. A statistically significant association was
found between the size of SCC of the oral tongue and
lymphovascular invasion (p < 0.05) (Table 3). Thirty
patients (69.77%) in therapeutic neck dissection and 15
patients (57.69%) in prophylactic neck dissection
showed lymphovascular invasion of the primary tumor.
Therapeutic neck dissections were performed in 43 pa-
tients (62.32%) and prophylactic neck dissections were
performed in 26 patients (37.68%). Thirty-five patients
(81.40%) in the therapeutic neck dissections and 18 pa-
tients (69.23%) in the prophylactic neck dissections
showed metastasis of SCC to the cervical nodes. Forty-
three patients underwent therapeutic neck dissection,
Table 1 Demographic data of 165 patients of HNSCC





< 45 years 36 21.82
45–60 years 83 50.30
> 60 years 46 27.88
Site of SCC of the oral cavity
Oral tongue 84 50.91
Base of the tongue 15 9.09
Lip 31 18.79
Floor of the mouth 19 11.51
Buccal mucosa 11 6.67
Retromolar trigone 5 3.03
Clinical staging
Stage I 99 60.00
Stage II 23 13.94
Stage III 23 13.94
Stage IV 20 12.12
Tumor size
≤ 1.0 cm 37 22.42
1.1–2.0 cm 65 39.39
2.1–3.0 cm 23 13.94
3.1–4.0 cm 27 16.36
> 4.0 cm 13 7.88
Pathologic differentiation
Well differentiated 86 52.12
Moderately differentiated 49 29.70
Poorly differentiated 25 15.15
Undifferentiated 5 3.03
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and 26 patients in prophylactic neck dissection group
generated 516 nodes (average 19.85 nodes per patient)
(Table 4). The most common size of cervical nodes was
1–3 mm. The mean size of nodes was 3.67 mm (range,
1–45 mm). Metastatic nodes totaled 289 nodes (19.63%).
In all, 204 nodes (21.34%) in the group of therapeutic
neck dissection showed metastasis, and the mean size of
metastatic nodes was 3.89 mm (range, 2–45 mm).
Eighty-five nodes (16.47%) in the prophylactic neck dis-
section group exhibited metastasis, and the mean size of
metastatic nodes was 3.53 mm (range of metastasis
nodes, 2–23 mm). In the therapeutic neck dissection
group, a statistical significance was found between the
size of cervical nodes and the site of primary tumor ofthe oral tongue, lip, and floor of the mouth (p < 0.05). In
the prophylactic neck dissection group, a statistical sig-
nificance was found between the size of cervical nodes
and the site of primary tumor of the oral tongue, base of
the tongue, and floor of the mouth (p < 0.05) (Table 4).
Among 289 metastatic nodes, 201 (69.55%) showed
extracapsular extension (Table 5). No statistical signifi-
cance was found among extracapsular extension of
cervical nodes and clinical staging, size of primary tumor,
pathologic differentiation, and size of cervical nodes. Ac-
cording to each site of tumor, the size of cervical lymph
node of SCC of the oral tongue was statistically significant
with size of tumor and tumor grading (p < 0.05) (Table 6).
The size of cervical lymph node of SCC of the lip was
statistically significant with clinical staging and tumor
grading (p < 0.05) (Table 7). No statistical significance was
observed among SCC of the base of the tongue, floor of
the mouth, buccal mucosa, and retromolar trigone and
clinical staging, size of primary tumor, and pathologic dif-
ferentiation (Tables 8, 9, 10, and 11).
Complications of neck dissection included wound in-
fection, partial skin flap necrosis, and prolonged seroma.
All complications were healed conservatively. Compli-
cations of neck dissection were found in six patients
(13.95%) in therapeutic neck dissection and three pa-
tients (11.54%) in prophylactic neck dissection. No
statistical significance was found among the complica-
tion rate between the therapeutic and prophylactic
neck dissections.
Discussion
HNSCC is one of the most common cancers. Morbidity
and mortality are related to regional and distant metas-
tasis. The number and size of cervical node metastasis
varies depending on the site, tumor differentiation, and
stage of primary tumor. Cervical node metastasis is an
important prognostic factor for HNSCC [12]. Kuperman
et al. revealed the relationship between the risk of dis-
tant metastasis and tumor site, size, and nodal status
[14]. The size of the cervical lymph node remains an
important factor in the interpretation of a clinically sus-
picious lymph node metastasis; however, it remains con-
troversial regarding the significance of the size of the
cervical node.
The accuracy of staging depends on the status of the
cervical node. Many methods have attempted to detect
the node status but no gold standard exists, except the
histopathologic examination. Some studies have reported
that the size of the cervical node was an inaccurate pre-
dictor of nodal metastasis and could not be regarded as
an accurate means of staging in patients with clinically
negative nodes [3,15]. Neck dissection is both a thera-
peutic and staging procedure and has evolved to include
various types with standardized level designations (I–VI)
Table 2 Characteristics of squamous cell carcinoma depend on the site of primary tumor
Site of cancer
Oral tongue Base of the tongue Lip Floor of the mouth Buccal mucosa Retromolar trigone
84 (%) 15 (%) 31 (%) 19 (%) 11 (%) 5 (%)
Clinical staging
Stage I 68 (80.95) 3 (20.00) 19 (61.29) 4 (21.05) 5 (45.45) 0 (0.00)
Stage II 3 (3.57) 5 (33.33) 6 (19.35) 6 (31.58) 2 (18.18) 1 (20.00)
Stage III 8 (9.52) 3 (20.00) 3 (9.68) 5 (26.32) 2 (18.18) 2 (40.00)
Stage IV 5 (5.95) 4 (26.67) 3 (9.68) 4 (21.05) 2 (18.18) 2 (40.00)
Tumor size
≤ 1.0 cm 22 (26.19) 1 (6.67) 11 (35.48) 2 (10.53) 1 (9.09) 0 (0.00)
1.1–2.0 cm 48 (57.14) 2 (13.33) 8 (25.81) 2 (10.53) 5 (45.45) 0 (0.00)
2.1–3.0 cm 4 (4.76) 4 (26.67) 7 (22.58) 6 (31.58) 2 (18.18) 0 (0.00)
3.1–4.0 cm 7 (8.33) 5 (33.33) 3 (9.68) 7 (22.58) 2 (18.18) 3 (60.00)
> 4.0 cm 3 (3.57) 3 (20.00) 2 (13.33) 2 (10.53) 1 (9.09) 2 (40.00)
Pathologic differentiation
Well differentiated 50 (59.52) 6 (40.00) 15 (48.39) 8 (42.11) 7 (63.63) 0 (0.00)
Moderately differentiated 24 (28.57) 4 (26.67) 8 (25.81) 8 (42.11) 2 (18.18) 3 (60.00)
Poorly differentiated 7 (8.33) 4 (26.67) 7 (22.58) 3 (15.79) 2 (18.18) 2 (40.00)
Undifferentiated 3 (3.57) 1 (6.67) 1 (3.23) 0 (0.00) 0 (0.00) 0 (0.00)
Neck dissection
Therapeutic 13 (15.48) 8 (53.33) 5 (16.13) 9 (47.37) 4 (36.36) 4 (80.00)
Prophylactic 3 (3.57) 7 (46.67) 7 (22.58) 6 (31.58) 2 (18.18) 1 (20.00)
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ging treatment among patients with clinically negative
nodes.
Ozer et al. suggested therapeutic neck dissection
among patients with clinically negative nodes because
pathologically positive nodes might be found in some
patients [16]. Some reports have shown pathologically
identified neck node metastasis occurred 34%–51% in
prophylactic neck dissections [12,13]. In our study,
41.82% of HNSCC performed neck dissection. We found
69.23% of prophylactic neck dissections showed nodal
metastasis with the size of the cervical lymph nodes
varying from 2 to 23 mm. Statistically significant associ-
ations were found between the size of cervical nodes
and the site of primary tumor of the oral tongue, base of
the tongue, and floor of the mouth. No statistical signifi-
cance was observed between the size of cervical nodes
and the site of primary tumor at the buccal mucosa, lip,
and retromolar trigone.
Di et al. reported the significance of the size of lymph
node and recurrence. The size of the cervical node
metastasis is the key risk factor in determining the de-
velopment of cervical recurrence. Patients presenting
extracapsular nodal spread and invasion of non-lymphatic
structures have a high risk of developing cervical recur-
rence [17].Fine needle aspiration (FNA) is one of the methods to
identify cervical node metastasis, but negative FNA
could not exclude metastasis at the cervical node. Senti-
nel node biopsy of the cervical node is controversial.
Broglie et al. reported the occult metastases detected by
sentinel node biopsy in patients with early HNSCC [18].
However, the current knowledge of sentinel lymph node
biopsy does not allow avoiding the indication of elective
neck dissection in clinical practice. Sentinel lymph node
biopsy cannot be considered the standard of care at this
time [19].
Many studies have attempted to identify preoperative
cervical node status, but most of them have been usually
inconclusive. Matsubara et al. indicated that F-18 FDG
PET/CT was potentially useful in diagnosing preopera-
tive nodal state [6]. Furthermore, a combined assessment
of SUVmax with nodal size could be significant when
identifying metastatic lymph nodes in HNSCC. Yamasaki
et al. reported 80% false negative PET results in lymph
nodes [7]. Kagawa et al. showed an increase in vascular-
ity is a characteristic of Doppler ultrasound findings in
small metastatic lymph nodes [8]. As the metastatic
lymph node size increases, blood flow signals become
scattered and the scattering index increases. Ding et al.
demonstrated MRI diagnostic criteria of cervical lymph
node metastasis include nodal size, central nodal necrosis,
Table 3 Lymphovascular invasion of primary tumor
Lymphovascular invasion
Oral tongue p valuea Base of the tongue p valuea Lip p valuea Floor of the mouth p valuea Buccal mucosa p valuea Retromolar trigone p valuea
(84) (15) (31) (19) (11) (5)
+ − + − + − + − + − + −
Clinical staging 0.127 0.825 0.595 0.898 0.547 NA
Stage I 25 43 2 1 12 7 2 2 2 3 0 0
Stage II 2 1 2 2 2 4 4 2 1 1 1 0
Stage III 6 2 2 1 2 1 3 2 2 0 2 0
Stage IV 3 2 4 1 2 1 3 1 1 1 1 1
Tumor size 0.012 0.800 0.266 0.546 0.662 NA
≤ 1.0 cm 3 19 0 1 6 5 0 1 1 0 0 0
1.1–2.0 cm 23 25 1 1 7 1 1 1 3 2 0 0
2.1–3.0 cm 3 1 3 1 2 4 4 2 2 1 0 0
3.1–4.0 cm 5 2 4 1 2 1 4 3 3 0 2 1
> 4.0 cm 2 1 2 1 1 2 2 0 1 1 2 0
Pathologic differentiation 0.339 0.804 0.843 0.564 NA NA
Well differentiated 22 28 3 3 9 5 6 2 5 2 0 0
Moderately differentiated 8 16 2 2 4 5 4 4 2 0 2 0
Poorly differentiated 5 2 1 3 4 3 1 2 1 1 0 0
Undifferentiated 1 2 1 0 1 0 0 0 0 0 2 1
Neck dissection 1.000 0.608 1.000 1.000 1.000 NA
Therapeutic 9 4 6 2 3 2 6 3 3 1 3 1
Prophylactic 2 1 4 3 3 4 4 2 1 1 1 0
aChi-square test or Fisher’ s exact test.













Table 4 Size of neck node and metastasis
Size of neck node Oral tongue p valuea Base of the tongue p valuea Lip p valuea Floor of the mouth p valuea Buccal mucosa p valuea Retromolar trigone p valuea
(410) (319) (238) (231) (159) (115)
+ − + − + − + − + − + −
Therapeutic neck dissection <0.001 0.072 0.012 0.002 0.231 0.682
1–3 mm 7 78 5 35 3 27 2 40 2 18 2 12
4–6 mm 10 61 7 42 5 29 6 25 5 14 3 7
7–9 mm 11 31 7 39 6 38 9 28 7 21 5 10
10–30 mm 31 53 16 36 18 33 13 19 9 21 12 33
> 30 mm 1 1 0 0 0 0 0 0 2 1 0 0
Prophylactic neck dissection 0.006 0.013 0.150 0.007 0.628 0.898
1–3 mm 2 34 2 26 1 12 2 28 1 11 1 4
4–6 mm 4 28 4 32 2 14 3 21 2 14 1 4
7–9 mm 4 30 5 35 2 21 3 17 3 17 2 7
10–30 mm 9 15 10 18 8 19 7 8 3 8 4 8
> 30 mm 0 0 0 0 0 0 0 0 0 0 0 0
aChi-square test or Fisher’ s exact test.













Table 5 Analysis of extracapsular extension of metastasis cervical node in each site of SCC
Extracapsular extension
Oral tongue p valuea Base of the tongue p valuea Lip p valuea Floor of the mouth p valuea Buccal mucosa p valuea Retromolar trigone p valuea
(79) (56) (45) (45) (34) (30)
+ − + − + − + − + − + −
Clinical staging 0.465 0.518 0.195 0.255 0.891 0.634
Stage I 0 0 5 5 0 0 0 0 0 0 0 0
Stage II 6 4 11 6 9 8 8 6 3 2 2 2
Stage III 25 11 9 5 12 3 12 3 10 4 9 5
Stage IV 26 7 12 3 10 3 13 3 10 5 9 3
Tumor size 0.121 0.318 0.433 0.865 0.898 1.000
≤ 1.0 cm 0 0 3 4 0 0 0 0 0 0 0 0
1.1–2.0 cm 3 4 3 4 0 0 0 0 0 0 0 0
2.1–3.0 cm 11 7 11 3 13 8 11 5 7 4 0 0
3.1–4.0 cm 19 5 13 5 8 4 15 5 8 4 11 6
> 4.0 cm 24 6 7 3 10 2 7 2 8 3 9 4
Pathologic differentiation 0.874 0.447 0.718 0.474 0.654 0.705
Well differentiated 21 7 10 9 7 5 10 6 7 3 8 5
Moderately differentiated 25 9 12 5 8 2 15 4 7 2 0 0
Poorly differentiated 6 3 11 3 10 5 8 2 9 6 12 5
Undifferentiated 5 3 4 2 6 2 0 0 0 0 0 0
Size of neck node 0.506 0.793 0.849 0.968 0.824 0.994
1–3 mm 5 4 4 3 3 1 3 1 2 1 2 1
4–6 mm 9 5 7 4 4 3 6 3 4 3 3 1
7–9 mm 11 4 9 3 6 2 9 3 6 4 5 2
10–30 mm 31 9 17 9 18 8 15 5 9 3 10 6
> 30 mm 1 0 0 0 0 0 0 0 2 0 0 0
aChi-square test or Fisher’ s exact test.













Table 7 Size of lymph node and metastasis in squamous cell carcinoma of lip
Size of cervical node
1–3 mm p valuea 4–6 mm p valuea 7–9 mm p valuea 10–30 mm p valuea >30 mm p valuea
+ − + − + − + − + −
4 39 7 43 8 59 26 52 0 0
Clinical staging 0.344 0.492 0.238 0.015 NA
Stage I 0 0 0 0 0 0 0 0 0 0
Stage II 0 14 1 16 1 17 15 15 0 0
Stage III 2 12 3 14 2 23 8 16 0 0
Stage IV 2 13 3 13 5 19 3 21 0 0
Tumor size 0.804 0.832 0.832 0.081 NA
≤ 1.0 cm 0 0 0 0 0 0 0 0
1.1–2.0 cm 0 0 0 0 0 0 0 0 0 0
2.1–3.0 cm 2 14 3 17 3 18 13 15 0 0
3.1–4.0 cm 1 16 2 17 2 21 7 19 0 0
> 4.0 cm 1 9 2 9 3 20 6 24 0 0
Pathologic differentiation 0.776 0.709 0.907 <0.001 NA
Well differentiated 1 14 2 18 3 18 6 27 0 0
Moderately differentiated 2 11 2 14 2 18 4 19 0 0
Poorly differentiated 1 10 2 9 2 11 10 4 0 0
Undifferentiated 0 4 1 2 1 12 6 2 0 0
aChi-square test or Fisher’ s exact test.
+ metastasis of SCC to cervical node, − no metastasis of SCC to cervical node.
Table 6 Size of cervical lymph node and metastasis in oral tongue squamous cell carcinoma
Size of cervical node
1–3 mm p valuea 4–6 mm p valuea 7–9 mm p valuea 10–30 mm p valuea >30 mm p valuea
+ − + − + − + − + −
9 112 14 89 15 61 40 68 1 1
Clinical staging 0.354 0.794 0.576 0.320 NA
Stage I 0 0 0 0 0 0 0 0 0 0
Stage II 0 9 2 8 4 11 4 12 0 0
Stage III 3 54 6 44 5 29 22 28 0 0
Stage IV 6 49 6 37 6 21 14 28 1 1
Tumor size 0.033 0.467 0.915 0.140 NA
≤ 1.0 cm 0 0 0 0 0 0 0 0 0 0
1.1–2.0 cm 1 61 3 10 3 9 0 0 0 0
2.1–3.0 cm 3 15 4 18 6 24 5 15 0 0
3.1–4.0 cm 2 24 3 36 3 17 16 33 0 0
> 4.0 cm 3 12 4 25 3 11 19 20 1 1
Pathologic differentiation 0.044 0.711 0.278 0.028 NA
Well differentiated 2 58 4 35 4 29 18 24 0 0
Moderately differentiated 2 32 6 27 7 14 19 22 0 0
Poorly differentiated 4 13 2 18 2 11 1 12 0 0
Undifferentiated 1 9 2 9 2 7 2 10 1 1
aChi-square test or Fisher’ s exact test.
+ metastasis of SCC to cervical node, − no metastasis of SCC to cervical node.
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Table 9 Size of lymph node and metastasis of squamous cell carcinoma of the floor of the mouth
Size of cervical node
1–3 mm p valuea 4–6 mm p valuea 7–9 mm p valuea 10–30 mm p valuea >30 mm p valuea
+ − + − + − + − + −
4 68 9 46 12 45 20 27
Clinical staging 0.591 0.598 0.437 0.946 NA
Stage I 0 0 0 0 0 0 0 0 0 0
Stage II 1 23 2 16 5 13 6 7 0 0
Stage III 1 27 3 17 5 16 6 9 0 0
Stage IV 2 18 4 13 2 16 8 11 0 0
Tumor size 0.859 0.913 0.347 0.871 NA
≤ 1.0 cm 0 0 0 0 0 0 0 0
1.1–2.0 cm 0 0 0 0 0 0 0 0 0 0
2.1–3.0 cm 1 19 3 17 5 18 7 8 0 0
3.1–4.0 cm 1 24 4 17 6 15 9 12 0 0
> 4.0 cm 2 25 2 12 1 12 4 7 0 0
Pathologic differentiation 0.933 0.803 0.868 0.186 NA
Well differentiated 2 31 4 21 6 19 4 10 0 0
Moderately differentiated 1 23 2 14 4 16 12 9 0 0
Poorly differentiated 1 14 3 11 2 10 4 8 0 0
Undifferentiated 0 0 0 0 0 0 0 0 0 0
aChi-square test or Fisher’ s exact test.
+ metastasis of SCC to cervical node, − no metastasis of SCC to cervical node.
Table 8 Size of lymph node and metastasis of squamous cell carcinoma of the base of the tongue
Size of cervical node
1–3 mm p valuea 4–6 mm p valuea 7–9 mm p valuea 10–30 mm p valuea >30 mm p valuea
+ − + − + − + − + −
7 61 11 74 12 74 26 54 0 0
Clinical staging 0.280 0.976 0.602 0.999 NA
Stage I 1 11 2 11 3 9 4 8 0 0
Stage II 1 23 3 25 4 28 9 19 0 0
Stage III 2 18 3 19 2 21 7 14 0 0
Stage IV 3 9 3 19 3 16 6 13 0 0
Tumor size 0.441 0.413 0.756 0.161 NA
≤ 1.0 cm 0 8 1 5 1 7 5 6
1.1–2.0 cm 1 14 2 5 2 5 2 6 0 0
2.1–3.0 cm 1 17 2 27 2 21 9 12 0 0
3.1–4.0 cm 3 15 3 27 4 21 8 13 0 0
> 4.0 cm 2 7 3 10 3 20 2 17 0 0
Pathologic differentiation 0.546 0.948 0.765 0.587 NA
Well differentiated 4 21 5 30 4 34 6 18 0 0
Moderately differentiated 2 17 3 22 3 20 9 18 0 0
Poorly differentiated 1 14 2 13 3 12 8 10 0 0
Undifferentiated 0 9 1 9 2 8 3 8 0 0
aChi-square test or Fisher’ s exact test.
+ metastasis of SCC to cervical node, − no metastasis of SCC to cervical node.
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Table 11 Size of lymph node and metastasis in squamous cell carcinoma of retromolar trigone
Size of cervical node
1–3 mm p valuea 4–6 mm p valuea 7–9 mm p valuea 10–30 mm p valuea >30 mm p valuea
+ − + − + − + − + −
3 16 4 11 7 17 16 41
Clinical staging 0.484 0.880 0.931 0.231 NA
Stage I 0 0 0 0 0 0 0 0 0 0
Stage II 0 5 1 3 2 5 1 11 0 0
Stage III 1 5 1 4 3 6 9 18 0 0
Stage IV 2 6 2 4 2 6 6 12 0 0
Tumor size 0.582 1.000 0.659 0.082 NA
≤ 1.0 cm 0 0 0 0 0 0 0 0 0 0
1.1–2.0 cm 0 0 0 0 0 0 0 0 0 0
2.1–3.0 cm 0 0 0 0 0 0 0 0 0 0
3.1–4.0 cm 1 9 2 6 3 10 11 17 0 0
> 4.0 cm 2 7 2 5 4 7 5 24 0 0
Pathologic differentiation 0.546 0.569 1.000 0.379 NA
Well differentiated 1 10 3 5 3 9 6 22 0 0
Moderately differentiated 0 0 0 0 0 0 0 0 0 0
Poorly differentiated 2 6 1 6 4 8 10 19 0 0
Undifferentiated 0 0 0 0 0 0 0 0 0 0
aChi-square test or Fisher’ s exact test.
+ metastasis of SCC to cervical node, − no metastasis of SCC to cervical node.
Table 10 Size of lymph node and metastasis in squamous cell carcinoma of buccal mucosa
Size of cervical node
1–3 mm p valuea 4–6 mm p valuea 7–9 mm p valuea 10–30 mm p valuea >30 mm p valuea
+ − + − + − + − + −
3 29 7 28 10 38 12 29 2 1
Clinical staging 0.468 0.525 0.686 0.553 NA
Stage I 0 0 0 0 0 0 0 0 0 0
Stage II 0 7 1 9 2 13 2 9 0 0
Stage III 1 12 4 10 4 13 5 12 0 0
Stage IV 2 10 2 9 4 12 5 8 2 1
Tumor size 0.392 0.870 0.413 0.686 NA
≤ 1.0 cm 0 0 0 0 0 0 0 0 0 0
1.1–2.0 cm 0 0 0 0 0 0 0 0 0 0
2.1–3.0 cm 0 8 2 7 2 14 7 13 0 0
3.1–4.0 cm 1 12 3 10 5 11 3 8 0 0
> 4.0 cm 2 9 2 11 3 13 2 8 2 1
Pathologic differentiation 0.988 0.975 0.603 0.240 NA
Well differentiated 1 11 3 12 2 14 4 12 0 0
Moderately differentiated 1 9 2 9 4 12 2 10 0 0
Poorly differentiated 1 9 2 7 4 12 6 7 2 1
Undifferentiated 0 0 0 0 0 0 0 0 0 0
aChi-square test or Fisher’ s exact test.
+ metastasis of SCC to cervical node, − no metastasis of SCC to cervical node.
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MRI criteria have improved the detection of lymph node
metastases in head and neck squamous cell carcinoma [4].
However, Feinmesser et al. argued that little advantage
was achieved from MRI over clinical examination when
detecting metastatic neck disease, and the present size cri-
terion for the diagnosis of occult malignant nodes is not
reliable [3].
Many methods have identified prognostic factors of
HNSCC. Moreover, the biomarker study for prognostic
factors such as MMP-13 [9], COX-2 expression [10],
and gene expression (molecular analysis) marker [11]
can predict occult metastasis, but the accuracy to detect
occult metastasis is inconclusive.
Jan et al. reported the importance of tumor stage, sur-
gical margin status, and extracapsular spread of cervical
nodal metastasis as the most important prognostic fac-
tors in patients with buccal SCC [20]. Apisarnthanarax
et al. found no significant difference between the extent
of extracapsular extension and lymph node size. The in-
cidence of extracapsular extension is associated with lar-
ger nodal size [21]. However, extracapsular extension is
found in a substantial number of nodes with a diameter
of <10 mm [22]. In our study, we found extracapsular
extension 69.55% and no statistical significance among
extracapsular extension of cervical nodes and staging,
size of primary tumor, pathologic differentiated, and size
of cervical node.
In our study, the size of cervical node ranges from 1 to
40 mm and the size of cervical node metastasis can be
found as small as 2 mm. A statistical significance was
found between the size of cervical nodes and the site of
primary tumor of the oral tongue and lip (p < 0.05). We
recommended performing neck dissection in all cases of
SCC of the base of the tongue, floor of the mouth, buc-
cal mucosa, and retromolar trigone. According to each
site of tumor, the size of cervical lymph node of SCC of
the oral tongue was statistically significant with the size
of tumor and tumor grading. The size of cervical lymph
node of SCC of the lip was statistically significant with
clinical staging and tumor grading. However, the size of
primary tumor and tumor grading association with the
cervical nodes status were inconclusive.
In therapeutic neck dissection, statistically significant
associations were found between the size of cervical
lymph node and SCC of the oral tongue, lip, and floor of
the mouth. In prophylactic neck dissection, statistically
significant associations were observed between the size
of cervical lymph node and SCC of the oral tongue, base
of the tongue, and floor of the mouth. It meant that the
larger the primary tumor, the higher the chance of me-
tastasis, while SCC of the base of the tongue, floor of
the mouth, buccal mucosa and retromolar trigone had
the cervical node metastasis in small primary tumors.Herein, we recommended performing neck dissection, in
cases of SCC of the base of the tongue, floor of the
mouth, buccal mucosa, and retromolar trigone.
No statistically significant associations were found
among extracapsular extension of the cervical node and
clinical staging, size of primary tumor, pathologic differen-
tiation, and size of cervical nodes. No statistically signifi-
cant associations were observed among lymphovascular
invasion of primary tumor, clinical staging, and pathologic
differentiation. A statistically significant association was
found between the size of SCC at the oral tongue and lym-
phovascular invasion. The importance of extracapsular ex-
tension and lymphovascular invasion is still unclear and
further data is needed to support the prognosis.
One disadvantage of this study was that the pathologic
status of the cervical node could not be determined in
the patients which neck dissection was not performed.
Additionally, we did not define the level of cervical
nodes, despite the fact that cervical node levels I and II
may increase the chance of node metastasis more than
cervical node levels III and IV because this was a retro-
spective review with insufficient data. Moreover, a numer-
ical difference between the tumor sites was observed, due
to the incidence of sites of primary tumors was different.
We did not study the survival rate of patients but empha-
sized the size of the metastatic cervical lymph node.
Conclusions
The status of cervical lymph nodes is one of the prognos-
tic factors in HNSCC. No gold standard exists, except the
histopathologic examination to identify nodal status. The
size of cervical node metastasis can be found as small as 2
mm. A statistical significance was found between the size
of cervical nodes and the site of primary tumor of the oral
tongue and lip. Herein, we recommended performing
neck dissection in all cases of SCC of the base of the
tongue, floor of the mouth, buccal mucosa, and retromo-
lar trigone.
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